Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty-Reference-Cited by-同舟云学术

Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

Published:2023-10 Issue:4 Volume:84 Page:381-389
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bamias Aristotelis^ORCID,Stenzl Arnulf,Brown Stephanie L.,Albiges Laurence,Babjuk Marko,Birtle Alison,Briganti Alberto,Burger Maximilian,Choudhury Ananya,Colecchia Maurizio,De Santis Maria,Fanti Stefano,Fonteyne Valérie,Gallucci Michele,Rivas Juan Gómez,Huddart Robert,Junker Kerstin,Kroeze Stephanie,Loriot Yohann,Merseburger Axel,Montironi Rodolfo,Necchi Andrea,Oing Christoph,Oldenburg Jan,Ost Piet,Pinkawa Michael,Ribal Maria J.,Rouprêt Morgan,Thoeny Harriet,Zilli Thomas,Hoskin Peter

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Epidemiology of bladder cancer;Saginala;Med Sci,2020

3. Current perspectives in bladder cancer management;Griffiths;Int J Clin Pract,2013

4. Oligometastases;Hellman;J Clin Oncol,1995

5. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies;Petrelli;F1000Res,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OligoM-Cancer: A multidimensional information platform for deep phenotyping of heterogenous oligometastatic cancer;Computational and Structural Biotechnology Journal;2024-12

2. Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study;Scientific Reports;2024-08-27

3. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases;International Journal of Urology;2024-07-15

4. Metastasis-directed therapy among urological malignancies: where do we stand?;Current Opinion in Urology;2024-06-06

5. Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels;European Urology Oncology;2024-06